Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice

Clinical and Experimental Metastasis

Volumn 21, Issue 3, 2004, Pages 213-221

  Nishikawa, Makiya ^a   Tamada, Ayumi ^a   Hyoudou, Kenji ^a   Umeyama, Yukari ^a   Takahashi, Yuki ^a   Kobayashi, Yuki ^a   Kumai, Hitomi ^a   Ishida, Emi ^a   Staud, Frantisek ^a   Yabe, Yoshiyuki ^a   Takakura, Yoshinobu ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

asialoglycoprotein receptor; catalase; matrix metalloproteinase; metastasis; reactive oxygen species

Indexed keywords

CATALASE; GALACTOSE; MATRIX METALLOPROTEINASE; RECOMBINANT ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; COLON CARCINOMA; DRUG EFFECT; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL MOUSE; LIVER; LIVER CELL; LIVER METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN TARGETING; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

ANIMALS; CATALASE; COLONIC NEOPLASMS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS;

EID: 4344623878     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000037706.13747.5e     Document Type: Article

References (45)

1. Engers R, Gabbert HE. Mechanisms of tumor metastasis: Cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000; 126: 682-92.
2. Onoda JM, Piechocki MP, Honn KV. Radiation-induced increase in expression of the αIIβ3 integrin in melanoma cells: Effects on metastatic potential. Radiat Res 1992; 130: 281-8.
3. Sellak H, Franzini E, Hakim J et al. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 1994; 83: 2669-77.
4. Shaughnessy SG, Whaley M, Lafrenie RM et al. Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch Biochem Biophys 1993; 304: 314-21.
5. Rajagopalan S, Meng XP, Ramasamy S et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-9.
6. 2 exposure. Lab Invest 1997; 77: 533-9.
7. Mukai M, Shinkai K, Tateishi R et al. Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res 1987; 47: 2167-71.
8. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659-65.
9. Adamson IY, Young L, Orr FW. Tumor metastasis after hyperoxic injury and repair of the pulmonary endothelium. Lab Invest 1987; 57: 71-7.
10. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-8.
11. Ben-Yoseph O, Ross BD. Oxidation therapy: The use of a reactive oxygen species-generating enzyme system for tumour treatment. Br J Cancer 1994; 70: 1131-5.
12. Fang J, Sawa T, Akaike T et al. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Res 2002; 62: 3138-43.
13. Jessup JM, Battle P, Waller H et al. Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res 1999; 59: 1825-9.
14. Mavier P, Guigui B, Preaux AM et al. In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes: Role of catalase and of the glutathione redox cycle. Hepatology 1988; 8: 1673-8.
15. Van Driel BE, Van Noorden CJ. Oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity for the discrimination between nonmalignant and malignant cells. J Histochem Cytochem 1999; 47: 575-82.
16. Malafa M, Margenthaler J, Webb B et al. MnSOD expression is increased in metastatic gastric cancer. J Surg Res 2000; 88: 130-134.
17. Nonaka Y, Iwagaki H, Kimura T et al. Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer 1993; 54: 983-6.
18. Yoshizaki N, Mogi Y, Muramatsu H et al. Suppressive effect of recombinant human Cu, Zn-superoxide dismutase on lung metastasis of murine tumor cells. Int J Cancer 1994; 57: 287-92.
19. Fujita T, Nishikawa M, Tamaki C et al. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J Pharmacol Exp Ther 1992; 263: 971-8.
20. Yabe Y, Koyama Y, Nishikawa M et al. Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice. Free Radic Res 1999; 30: 265-74.
21. Nishikawa M, Ohtsubo Y, Ohno J et al. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int J Pharm 1992; 85: 75-85.
22. Takakura Y, Fujita T, Furitsu H et al. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors. Int J Pharm 1994; 105: 19-29.
23. Fujita T, Furitsu H, Nishikawa M et al. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biochem Biophys Res Commun 1992; 189: 191-6.
24. Yabe Y, Nishikawa M, Tamada A et al. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 1999; 289: 1176-84.
25. Mihara K, Oka Y, Sawai K et al. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol. J Drug Target 1994; 2: 317-21.
26. Yabe Y, Kobayashi N, Nishihashi T et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by SOD and catalase derivatives. J Pharmacol Exp Ther 2001; 298: 894-9.
27. Nishikawa M, Tamada A, Kumai H et al. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer 2002; 99: 474-9.
28. Miyahara T, Samejima T. Effects of halide ions on porcine kidney catalase. J Biochem 1982; 91: 525-35.
29. Thakur ML, Coleman RE, Welch MJ. Indium-111-labeled leukocytes for the localization of abscesses: Preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med 1977; 89: 217-28.
30. Safford SE, Oberley TD, Urano M et al. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res 1994; 54: 4261-5.
31. Anasagasti MJ, Alvarez A, Martin JJ et al. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology 1997; 25: 840-6.
32. Kogawa K, Muramatsu H, Tanaka M et al. Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin. Clin Exp Metast 1999; 17: 239-44.
33. Tanaka M, Kogawa K, Nishihori Y et al. Suppression of intracellular Cu-Zn SOD results in enhanced motility and metastasis of Meth A sarcoma cells. Int J Cancer 1997; 73: 187-92.
34. Takenaga M, Igarashi R, Ochiai A, Mizushima Y. Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice. Free Radic Biol Med 1999; 26: 1117-25.
35. Blood CH, Zetter BR. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
36. Pearson HJ, Anderson J, Chamberlain J et al. The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunol Immunother 1986; 23: 214-6.
37. Bayon LG, Izquierdo MA, Sirovich I et al. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996; 23: 1224-31.
38. Phillips NC. Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity. Cancer Metast Rev 1989; 8: 231-52.
39. Rushfeldt C, Sveinbjornsson B, Seljelid R et al. Early events of hepatic metastasis formation in mice: Role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res 1999; 82: 209-15.
40. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-26.
41. Curran S, Murray GI. Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-30.
42. Wenk J, Brenneisen P, Wlaschek M et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 1999; 274: 25869-76.
43. Nelson KK, Ranganathan AC, Mansouri J et al. Elevated sod2 activity augments matrix metalloproteinase expression: Evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003; 9: 424-32.
44. Tamura Y, Watanabe F, Nakatani T et al. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J Med Chem. 1998; 41: 640-9.
45. Haruyama T, Ajioka I, Akaike T et al. Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem Biophys Res Commun 2000; 272: 681-6.